This page presents legal and compliance issues such as HIPAA, CLIA, expert witness policies, and letter templates related to legal issues.
Please login to see the members-only version of this page. Items submitted by members have been provided voluntarily for other members to make use of in their practices.
- HIPAA 5010
- HIPAA FAQs
- Expert Witness Policies
Summary: The ACR is concerned that without a change in the Commercial Activity Tax (CAT) law in Ohio, the existing law will adversely affect those rheumatology patients who receive intravenously infused drugs.
Ohio Sales Tax Issue on Infused Drugs from a member; requires login